Resmed INC DEF 14A proxy statements

ResMed Inc. announces its 2025 Annual Meeting of Stockholders, outlining proposals including director elections, auditor ratification, executive compensation, and incentive plan amendments.

ResMed reports strong fiscal year 2025 financial performance, driven by innovation and digital health expansion, while proposing key governance updates and board changes.

ResMed Inc. issues an amendment to its proxy statement to correct a scrivener's error in the Notice of Annual Meeting of Stockholders regarding the telephone number for voting and the website address for accessing the proxy statement and annual report.

ResMed Inc. will hold its annual meeting on November 20, 2024, to vote on the election of directors, ratification of the auditor, and executive compensation.

ResMed's proxy statement outlines the company's fiscal 2024 highlights, strategic initiatives, and executive compensation, focusing on long-term value creation and stakeholder engagement.